Cargando…
Serological immune response following ChAdOx1 nCoV-19 vaccine (Covishield) in patients with liver cirrhosis
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352377/ http://dx.doi.org/10.1016/j.jceh.2022.07.119 |
| _version_ | 1784762640948527104 |
|---|---|
| author | Katiyar, Harshita Goel, Amit Tiwari, Prachi Aggarwal, Amita Verma, Alka Khetan, Dhiraj Rajput, Mayank Krishna Kishore, Ravi V. Kumar, Pankaj Singh, Thakur Prashant Sheikh, Sabreena Pathak, Piyush Shalimar |
| author_facet | Katiyar, Harshita Goel, Amit Tiwari, Prachi Aggarwal, Amita Verma, Alka Khetan, Dhiraj Rajput, Mayank Krishna Kishore, Ravi V. Kumar, Pankaj Singh, Thakur Prashant Sheikh, Sabreena Pathak, Piyush Shalimar |
| author_sort | Katiyar, Harshita |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9352377 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93523772022-08-05 Serological immune response following ChAdOx1 nCoV-19 vaccine (Covishield) in patients with liver cirrhosis Katiyar, Harshita Goel, Amit Tiwari, Prachi Aggarwal, Amita Verma, Alka Khetan, Dhiraj Rajput, Mayank Krishna Kishore, Ravi V. Kumar, Pankaj Singh, Thakur Prashant Sheikh, Sabreena Pathak, Piyush Shalimar J Clin Exp Hepatol Article Elsevier 2022 2022-08-05 /pmc/articles/PMC9352377/ http://dx.doi.org/10.1016/j.jceh.2022.07.119 Text en . Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Katiyar, Harshita Goel, Amit Tiwari, Prachi Aggarwal, Amita Verma, Alka Khetan, Dhiraj Rajput, Mayank Krishna Kishore, Ravi V. Kumar, Pankaj Singh, Thakur Prashant Sheikh, Sabreena Pathak, Piyush Shalimar Serological immune response following ChAdOx1 nCoV-19 vaccine (Covishield) in patients with liver cirrhosis |
| title | Serological immune response following ChAdOx1 nCoV-19 vaccine (Covishield) in patients with liver cirrhosis |
| title_full | Serological immune response following ChAdOx1 nCoV-19 vaccine (Covishield) in patients with liver cirrhosis |
| title_fullStr | Serological immune response following ChAdOx1 nCoV-19 vaccine (Covishield) in patients with liver cirrhosis |
| title_full_unstemmed | Serological immune response following ChAdOx1 nCoV-19 vaccine (Covishield) in patients with liver cirrhosis |
| title_short | Serological immune response following ChAdOx1 nCoV-19 vaccine (Covishield) in patients with liver cirrhosis |
| title_sort | serological immune response following chadox1 ncov-19 vaccine (covishield) in patients with liver cirrhosis |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352377/ http://dx.doi.org/10.1016/j.jceh.2022.07.119 |
| work_keys_str_mv | AT katiyarharshita serologicalimmuneresponsefollowingchadox1ncov19vaccinecovishieldinpatientswithlivercirrhosis AT goelamit serologicalimmuneresponsefollowingchadox1ncov19vaccinecovishieldinpatientswithlivercirrhosis AT tiwariprachi serologicalimmuneresponsefollowingchadox1ncov19vaccinecovishieldinpatientswithlivercirrhosis AT aggarwalamita serologicalimmuneresponsefollowingchadox1ncov19vaccinecovishieldinpatientswithlivercirrhosis AT vermaalka serologicalimmuneresponsefollowingchadox1ncov19vaccinecovishieldinpatientswithlivercirrhosis AT khetandhiraj serologicalimmuneresponsefollowingchadox1ncov19vaccinecovishieldinpatientswithlivercirrhosis AT rajputmayank serologicalimmuneresponsefollowingchadox1ncov19vaccinecovishieldinpatientswithlivercirrhosis AT krishnakishoreraviv serologicalimmuneresponsefollowingchadox1ncov19vaccinecovishieldinpatientswithlivercirrhosis AT kumarpankaj serologicalimmuneresponsefollowingchadox1ncov19vaccinecovishieldinpatientswithlivercirrhosis AT singhthakurprashant serologicalimmuneresponsefollowingchadox1ncov19vaccinecovishieldinpatientswithlivercirrhosis AT sheikhsabreena serologicalimmuneresponsefollowingchadox1ncov19vaccinecovishieldinpatientswithlivercirrhosis AT pathakpiyush serologicalimmuneresponsefollowingchadox1ncov19vaccinecovishieldinpatientswithlivercirrhosis AT shalimar serologicalimmuneresponsefollowingchadox1ncov19vaccinecovishieldinpatientswithlivercirrhosis |